Sanofi Backs Away from mRNA Vaccines
French Pharmaceutical giant Sanofi, despite previous billion-dollar investments in the technology.
French pharmaceutical company Sanofi has announced that it is discontinuing development of its mRNA-based seasonal influenza vaccine – despite investing $3.2 billion in mRNA technology as recently as 2021. The announcement comes amid a turbulent period for the vaccine industry in the United States, where Health Secretary Robert F. Kennedy Jr. has withdr…
Keep reading with a 7-day free trial
Subscribe to The Norse Warrior to keep reading this post and get 7 days of free access to the full post archives.